ESR1 and breast carcinoma: Previous studies have already shown that the siRNA knockdown of ERα in MCF-7 breast cancer cells decreased COUP-TFII expression while treatment with estradiol increased the expression of COUP-TFII, revealing a positive correlation between COUP-TFII and ERα status (104).